Example: Heart Attack

Clinical Trials on Non-squamous Non-small-cell Lung Cancer

Total 176 results

NCT05853887

Not yet recruiting

Liquid Biopsy Based NGS in Newly Diagnosed NSCLC (iNUDGE)

Non Small Cell Lung Cancer Metastatic Non-Squamous Non-Small Cell Neoplasm of Lung Newly Diagnosed NSCLC
NCT05849246

Not yet recruiting

The Study of Tusamitamab Ravtansine (IBI126) Combined With Sintilimab and Tusamitamab Ravtansine (IBI126) Combined With Sintilimab Plus Platinum-based Chemotherapy and Pemetrexed in Subjects With CEACAM5 Positive Expression Advanced/Metastatic Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)

Non-squamous Non-small-cell Lung Cancer
NCT05692999

Recruiting

Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study (Pulse)

Metastatic Non-squamous Lung Cancer
NCT05652868

Recruiting

Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer NSCLC Advanced Non-Small Cell Lung Cancer NSCLC Stage IV NSCLC Stage IIIB Advanced Non-Small Cell Squamous Lung Cancer Advanced Non-Small Cell Non-Squamous Lung Cancer
NCT05648071

Recruiting

First-Line Treatment for Advanced Non-squamous Non-Small-Cell Lung Cancer With Negative Driver Gene: a Single-center, Single-Arm Trial (SPBPDC)

Advanced Non-squamous Non-Small-Cell Lung Cancer
NCT05585034

Recruiting

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Colorectal Cancer Castration-resistant Prostate Cancer Head and Neck Squamous Cell Carcinoma Urothelial Carcinoma Ovarian Cancer, Epithelial TNBC - Triple-Negative Breast Cancer Renal Cell Carcinoma, Clear Cell Melanoma Excluding Uveal Melanoma Non-small Cell Lung Cancer, Squamous or Non-squamous
NCT05403554

Recruiting

A Study of NI-1801 in Patients With Mesothelin Expressing Solid Cancers

Triple Negative Breast Cancer Epithelial Ovarian Cancer Non-squamous Non-small-cell Lung Cancer
NCT05394233

Not yet recruiting

Tislelizumab +Bevacizumab+pc for Untreated EGFR+ and High PD-L1 Non-squamous NSCLC

Non-squamous Non-small Cell Lung Cancer EGFR Gene Mutation
NCT05346952

Recruiting

A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the Treatment of First-line Non-squamous Non-small Cell Lung Cancer(NSCLC).

Advanced Non-squamous Non-small Cell Lung Cancer
NCT05338619

Recruiting

A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy (PLATINUM)

Non-small Cell Lung Cancer Stage III Non-squamous Non-small-cell Lung Cancer EGFR Positive Non-small Cell Lung Cancer
NCT05338970

Recruiting

HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

EGFR L858R EGFR Exon 19 Deletion Nonsquamous Non-small Cell Lung Cancer
NCT05318443

Recruiting

A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer

Non-squamous Non-small-cell Lung Cancer
NCT05258279

Recruiting

Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations

Non-squamous Non-small-cell Lung Cancer EGFR Activating Mutation
NCT05245071

Recruiting

Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA (CARMEN-LC06)

Non-squamous Non-small Cell Lung Cancer
NCT05242965

Recruiting

A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer

Stage IV Lung Cancer AJCC v8 Lung Non-Squamous Non-Small Cell Carcinoma
NCT05198830

Recruiting

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

Lung Adenocarcinoma Stage III Lung Cancer AJCC v8 Lung Non-Squamous Non-Small Cell Carcinoma Lung Large Cell Carcinoma
NCT05184712

Recruiting

Phase 3 Clinical Study of AK112 for NSCLC Patients

Non-Squamous Non-small Cell Lung Cancer
NCT05132413

Not yet recruiting

A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer

Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer
NCT05086692

Recruiting

A Beta-only IL-2 ImmunoTherapY (ABILITY) Study

Melanoma Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma Cervical Cancer Hepatocellular Carcinoma Gastric Cancer Colorectal Cancer Esophageal Cancer Solid Tumor Squamous Cell Carcinoma of Head and Neck
NCT05070247

Recruiting

A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Kidney Cancer Breast Cancer Nasopharyngeal Cancer Gastric Cancer Pancreatic Cancer Esophageal Cancer Mesothelioma Hepatocellular Cancer Squamous Cell Cancer of Head and Neck (SCCHN) Non-small Cell Lung Cancer (NSCLC), Non-squamous
NCT05017025

Recruiting

Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer

Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8 Stage III Lung Cancer AJCC v8 Stage IV Lung Cancer AJCC v8 Stage IIIA Lung Cancer AJCC v8 Stage IIIB Lung Cancer AJCC v8 Advanced Lung Non-Squamous Non-Small Cell Carcinoma Metastatic Lung Non-Squamous Non-Small Cell Carcinoma Stage IIIC Lung Cancer AJCC v8
NCT04974957

Not yet recruiting

Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors

Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer
NCT04958811

Recruiting

Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC

Non-squamous Non-small-cell Lung Cancer
NCT04750083

Recruiting

HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer

Nonsquamous Non-small Cell Lung Cancer
NCT04736173

Recruiting

Study Comparing the Combination Domvanalimab and Zimberelimab With Pembrolizumab in Untreated Locally Advanced or Metastatic PD-L1-High Non-Small Cell Lung Cancer (ARC-10)

Lung Cancer Non Small Cell Lung Cancer Squamous Non Small Cell Lung Cancer Nonsquamous Non Small Cell Lung Cancer
NCT04625647

Recruiting

Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Lung Adenocarcinoma Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8 Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8 Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
NCT04619433

Recruiting

A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.

Non-squamous Non-small-cell Lung Cancer
NCT04524689

Recruiting

Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC (CARMEN-LC05) (CARMEN-LC05)

Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)
NCT04310007

Recruiting

Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

Stage IV Lung Cancer AJCC v8 Metastatic Lung Non-Squamous Non-Small Cell Carcinoma Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
NCT04267848

Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer (An ALCHEMIST Treatment Trial)

Lung Non-Small Cell Carcinoma Lung Non-Small Cell Squamous Carcinoma Lung Non-Squamous Non-Small Cell Carcinoma Stage II Lung Cancer AJCC v8 Stage IIA Lung Cancer AJCC v8 Stage IIB Lung Cancer AJCC v8 Stage IIIA Lung Cancer AJCC v8 Stage IIIB Lung Cancer AJCC v8
NCT04181060

Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Stage IV Lung Cancer AJCC v8 Stage IIIB Lung Cancer AJCC v8 Advanced Lung Non-Squamous Non-Small Cell Carcinoma Metastatic Lung Non-Squamous Non-Small Cell Carcinoma Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
NCT04084717

Recruiting

Study of Crizotinib for ROS1 and MET Activated Lung Cancer

Non-squamous Non-small-cell Lung Cancer Stage IV Non-small Cell Lung Cancer ROS1 Gene Rearrangement MET Activating Mutation MET Amplification
NCT04032704

Recruiting

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

Melanoma Small Cell Lung Cancer Prostate Cancer Gastric Adenocarcinoma Head and Neck Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma Gastroesophageal Junction Adenocarcinoma Non-small Cell Lung Cancer, Squamous Non-small Cell Lung Cancer, Non-squamous
NCT03992885

Recruiting

Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.

Non-squamous Non-small Cell Lung Cancer
NCT03863483

Recruiting

A Study of Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Platinum-Containing Chemotherapy.

Nonsquamous Non-Small Cell Lung Cancer

Clinical Trials on Non-squamous Non-small-cell Lung Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations